tiprankstipranks

Kevin D. Freeman Insider Profile

4 Followers
Kevin D. Freeman, Director at Galectin Therapeutics, holds 119.03K shares in Galectin Therapeutics (Ticker: GALT). Most recently, Kevin D. Freeman Bought $2,500 shares of Galectin Therapeutics on Apr 22, 2024 for an estimated value of 7.45K.
tipranks
Kevin D. Freeman

Kevin D. Freeman
Galectin Therapeutics (GALT)
Director

Ranked #87,972 out of 98,909 Corporate Insiders

Profitable Transactions

33%
8 out of 24 Profitable Transactions

Average Return

-14.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$367K
100.00%
A breakdown of Kevin D. Freeman's holdings

Insider Roles

Galectin Therapeutics
(GALT)
Director
Roles that Kevin D. Freeman holds in companies

Most Profitable Insider Trade

Stock:
Galectin Therapeutics
(GALT)
Rating:Informative Buy
Date:Dec 08, 2017 - Dec 08, 2018
Return:+104.50%
The most profitable trade made by Kevin D. Freeman

Kevin D. Freeman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Galectin Therapeutics
Apr 22, 2024
Director
Informative Buy
7.45K
$366.62K
Success Rate for
GALT
8 out of 24 profitable transactions on
GALT
33%
Average Return for
GALT
Average return per transaction on
GALT
-14.45%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jun 03, 2011
Uninformative Buy
-
$7.86
May 28, 2013
Informative Buy
$4.21K
-
$4.21
Nov 19, 2013
Informative Buy
$6.07K
-
$6.07
Aug 18, 2014
Informative Buy
$4.70K
-
$4.70
-53.50%
Jun 02, 2015
Informative Buy
$5.62K
-
$2.70
-43.60%
List of latest transactions for each holding click on a transaction to see Kevin D. Freeman's performance on stock

Kevin D. Freeman insider profile FAQ

What is the percentage of profitable transactions made by Kevin D. Freeman?
The percentage of profitable transactions made by Kevin D. Freeman is 33%.
    What is the average return per transaction made by Kevin D. Freeman?
    The average return per transaction made by Kevin D. Freeman is -14.40%.
      What stocks does Kevin D. Freeman hold?
      Kevin D. Freeman holds: GALT stocks.
        What was Kevin D. Freeman’s latest transaction?
        Kevin D. Freeman latest transaction was an Informative Buy of $7.45K.
          What was Kevin D. Freeman's most profitable transaction?
          Kevin D. Freeman’s most profitable transaction was an Informative Buy of GALT stock on December 8, 2017. The return on the trade was 104.50%.
            What is Kevin D. Freeman's role in Galectin Therapeutics?
            Kevin D. Freeman's role in Galectin Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.